Celgene Corp - Company Profile
Powered by
All the data and insights you need on Celgene Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Celgene Corp Strategy Report
- Understand Celgene Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Celgene Corp’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
02 Sep 2021 | Celgene Exercises License Option Agreement with Evotec | Licensing Agreement |
Celgene Corp
|
Evotec SE |
13 Jul 2021 | Celgene Corp Enters Phase I Clinical Trial Agreement with Collaborative Neuroscience Network LLC for CC-99677 (GDCT0426379) | Contract Service Agreement |
Celgene Corp
|
Collaborative Neuroscience Network LLC
|
19 May 2021 | Juno Therapeutics Inc Enters Phase III Clinical Trial Agreement with Sarah Cannon Research Institute LLC for lisocabtagene maraleucel (GDCT0389460) | Contract Service Agreement |
Juno Therapeutics Inc
|
Sarah Cannon Research Institute LLC
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer